Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ligand Pharmaceuticals
Biotech
Ligand tries to disembark from Viking pact, alleging breach
Viking Therapeutics’ collaboration with Ligand has sailed into some trouble, with one of the partners keen to jettison part of the pact.
James Waldron
May 1, 2026 8:31am
Fierce Pharma
Ligand lays out $739M for royalty aggregator compatriot Xoma
Apr 27, 2026 10:19am
Orchestra BioMed scores $111M, backed by Medtronic, Ligand
Aug 5, 2025 3:41pm
Ovid sells some royalty rights to Takeda-partnered seizure drug
Oct 18, 2023 8:00am
Roche taps new North American diagnostics chief—Chutes & Ladders
Dec 9, 2022 9:30am
Ligand takes a crack at SPAC to buoy spun-off antibody business
Mar 24, 2022 11:07am
